Cargando…

The renal tubular damage marker urinary N-acetyl-β-d-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes

BACKGROUND: To determine the association between urinary N-acetyl-β-d-glucosaminidase (NAG), a marker of renal tubulopathy, and carotid intima-media thickness (IMT) and plaques in patients with type 2 diabetes mellitus (T2D) and to compare the predictive value of NAG versus albuminuria, a marker of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, So Ra, Lee, Yong-ho, Lee, Sang-Guk, Kang, Eun Seok, Cha, Bong-Soo, Lee, Byung-Wan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267389/ https://www.ncbi.nlm.nih.gov/pubmed/28122570 http://dx.doi.org/10.1186/s12933-017-0497-7

Ejemplares similares

Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus
por: Kim, Hae Kyung, et al.
Publicado: (2022)

Urinary N-acetyl-β-d-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes
por: Kim, So Ra, et al.
Publicado: (2016)

Urinary N-acetyl-beta-D-glucosaminidase and malondialdehyde as a markers of renal damage in burned patients.
por: Kang, H. K., et al.
Publicado: (2001)

Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes
por: Nauta, Ferdau L., et al.
Publicado: (2011)

Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients
por: Żyłka, Agnieszka, et al.
Publicado: (2018)

Urinary biomarker N-acetyl-β-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy
por: Sheira, Gehan, et al.
Publicado: (2015)

Correlation between glomerular filtration rate and urinary N acetyl-beta-D glucosaminidase in children with persistent proteinuria in chronic glomerular disease
por: Hong, Jeong Deok, et al.
Publicado: (2012)

Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker of Tubular Damage in Diabetic Nephropathy
por: Kim, So Young, et al.
Publicado: (2018)

Association of urinary non-albumin protein with the different urinary marker for glomerular and tubular damage in patients with type 2 diabetes
por: Siddiqui, Khalid, et al.
Publicado: (2020)

Renal markers for assessment of renal tubular and glomerular dysfunction
por: Spasovski, Dejan
Publicado: (2013)

Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis
por: de Borst, Martin H., et al.
Publicado: (2012)

Urinary N-Acetyl-beta-D-glucosaminidase as an Early Marker for Acute Kidney Injury in Full-Term Newborns with Neonatal Hyperbilirubinemia
por: Cheng, Bangning, et al.
Publicado: (2014)

Urinary N-acetyl-beta-d-glucosaminidase levels in diabetic adults
por: Omozee, Eiya Bibiana, et al.
Publicado: (2019)

New Markers of Inflammation and Tubular Damage in Children with Chronic Kidney Disease
por: Musiał, Kinga, et al.
Publicado: (2017)

Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers
por: Dekkers, Claire C. J., et al.
Publicado: (2018)

Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases?
por: Lopes, Tiago Giulianni, et al.
Publicado: (2019)

Asymmetric dimethylarginine is not a marker of arterial damage in children with glomerular kidney diseases
por: SKRZYPCZYK, PIOTR, et al.
Publicado: (2020)

PLVAP as an Early Marker of Glomerular Endothelial Damage in Mice with Diabetic Kidney Disease
por: Wolf, Elena E., et al.
Publicado: (2023)

Is Urinary Netrin-1 a Good Marker of Tubular Damage in Preterm Newborns?
por: Kamianowska, Monika, et al.
Publicado: (2021)

Air pollution and urinary n-acetyl-B-glucosaminidase levels in residents living near a cement plant
por: Jung, Min Soo, et al.
Publicado: (2016)

Renal tubular dysfunction measured by N-acetyl-beta glucosaminidase/Creatinine activity index in children receiving antiepileptic drugs: a randomized controlled trial
por: Mazaheri, Mojgan, et al.
Publicado: (2011)

Structural insights of two novel N-acetyl-glucosaminidase enzymes through in silico methods
por: ŞAHUTOĞLU, Arif Sercan, et al.
Publicado: (2020)

Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease
por: Nakagawa, Shunsaku, et al.
Publicado: (2015)

Association between Urinary N-Acetyl-Beta-D-Glucosaminidase and Microalbuminuria in Diabetic Black Africans
por: Udomah, Francis Patrick, et al.
Publicado: (2012)

Distribution of urinary N‐acetyl‐beta‐D‐glucosaminidase and the establishment of reference intervals in healthy adults
por: Liu, Qian, et al.
Publicado: (2021)

Neutrophil gelatinase-associated lipocalin as a marker of tubular damage appears to be unrelated to fractional excretion of sodium as a marker of tubular function in septic patients, with or without AKI
por: Glassford, NJ, et al.
Publicado: (2011)

Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study
por: Park, Hayne Cho, et al.
Publicado: (2012)

Elevated markers of DNA damage and senescence are associated with the progression of albuminuria and restrictive lung disease in patients with type 2 diabetes
por: Varun, Kumar, et al.
Publicado: (2023)

Albuminuria - marker of progressive renal disease
por: Stoian, M, et al.
Publicado: (2012)

The Role of Urinary N-Acetyl-β-d-glucosaminidase in Cirrhotic Patients with Acute Kidney Injury: Multicenter, Prospective Cohort Study
por: Yoo, Jeong-Ju, et al.
Publicado: (2021)

GlycA, a marker of protein glycosylation, is related to albuminuria and estimated glomerular filtration rate: the ELSA-Brasil study
por: Titan, Silvia M., et al.
Publicado: (2017)

Molecular modeling and analysis of human and plant endo-β-N-acetyl- glucosaminidases for mutations effects on function
por: Choragudi, Shechinah Felice, et al.
Publicado: (2014)

Urinary N-Acetyl-β-d-Glucosaminidase (NAG) Levels and Risk of Cardiovascular Events in Diabetic Patients
por: Lou, Weiwei, et al.
Publicado: (2021)

Urinary N-Acetyl-Beta-D-Glucosaminidase levels predict immunoglobulin a nephropathy remission status
por: Liu, Xiao, et al.
Publicado: (2023)

Elevated urinary N-acetyl-β-D-glucosaminidase is associated with high glycoalbumin-to-hemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease
por: Hong, Namki, et al.
Publicado: (2018)

Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without Nephropathy
por: Choi, Min Sun, et al.
Publicado: (2021)

Biochemical Markers of Myocardial Damage
por: Bodor, Geza S.
Publicado: (2016)

Residual N-acetyl-α-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB
por: Meijer, O. L. M., et al.
Publicado: (2016)

Electrochemical N-Acetyl-β-D-glucosaminidase Urinalysis: Toward Sensor Chip-Based Diagnostics of Kidney Malfunction
por: Vibulcharoenkitja, Piyanuch, et al.
Publicado: (2021)

Albuminuria and glomerular filtration rate in obese children and adolescents
por: Sawamura, Luciana Satiko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_irkqmi2oob6j463ujjqcggq5ht